1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Human Insulin Revenue
1.4 Market Analysis by Type
1.4.1 Global Human Insulin Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Insulin Analogs and Biosimilars
1.4.3 Human Insulin Biologics
1.5 Market by Application
1.5.1 Global Human Insulin Market Share by Application: 2021-2026
1.5.2 Short acting
1.5.3 Intermediate acting
1.5.4 Long acting
1.5.5 Pre-mix Insulin
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global Human Insulin Market
1.8.1 Global Human Insulin Market Status and Outlook (2015-2026)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global Human Insulin Production Capacity Market Share by Manufacturers (2015-2020)
2.2 Global Human Insulin Revenue Market Share by Manufacturers (2015-2020)
2.3 Global Human Insulin Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Human Insulin Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global Human Insulin Sales Volume Market Share by Region (2015-2020)
3.2 Global Human Insulin Sales Revenue Market Share by Region (2015-2020)
3.3 North America Human Insulin Sales Volume
3.3.1 North America Human Insulin Sales Volume Growth Rate (2015-2020)
3.3.2 North America Human Insulin Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.4 East Asia Human Insulin Sales Volume
3.4.1 East Asia Human Insulin Sales Volume Growth Rate (2015-2020)
3.4.2 East Asia Human Insulin Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.5 Europe Human Insulin Sales Volume (2015-2020)
3.5.1 Europe Human Insulin Sales Volume Growth Rate (2015-2020)
3.5.2 Europe Human Insulin Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.6 South Asia Human Insulin Sales Volume (2015-2020)
3.6.1 South Asia Human Insulin Sales Volume Growth Rate (2015-2020)
3.6.2 South Asia Human Insulin Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.7 Southeast Asia Human Insulin Sales Volume (2015-2020)
3.7.1 Southeast Asia Human Insulin Sales Volume Growth Rate (2015-2020)
3.7.2 Southeast Asia Human Insulin Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.8 Middle East Human Insulin Sales Volume (2015-2020)
3.8.1 Middle East Human Insulin Sales Volume Growth Rate (2015-2020)
3.8.2 Middle East Human Insulin Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.9 Africa Human Insulin Sales Volume (2015-2020)
3.9.1 Africa Human Insulin Sales Volume Growth Rate (2015-2020)
3.9.2 Africa Human Insulin Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.10 Oceania Human Insulin Sales Volume (2015-2020)
3.10.1 Oceania Human Insulin Sales Volume Growth Rate (2015-2020)
3.10.2 Oceania Human Insulin Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.11 South America Human Insulin Sales Volume (2015-2020)
3.11.1 South America Human Insulin Sales Volume Growth Rate (2015-2020)
3.11.2 South America Human Insulin Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.12 Rest of the World Human Insulin Sales Volume (2015-2020)
3.12.1 Rest of the World Human Insulin Sales Volume Growth Rate (2015-2020)
3.12.2 Rest of the World Human Insulin Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
4 North America
4.1 North America Human Insulin Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 East Asia
5.1 East Asia Human Insulin Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 Europe
6.1 Europe Human Insulin Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 South Asia
7.1 South Asia Human Insulin Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 Southeast Asia
8.1 Southeast Asia Human Insulin Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 Middle East
9.1 Middle East Human Insulin Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 Africa
10.1 Africa Human Insulin Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 Oceania
11.1 Oceania Human Insulin Consumption by Countries
11.2 Australia
11.3 New Zealand
12 South America
12.1 South America Human Insulin Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 Rest of the World
13.1 Rest of the World Human Insulin Consumption by Countries
13.2 Kazakhstan
14 Sales Volume, Sales Revenue, Sales Price Trend by Type
14.1 Global Human Insulin Sales Volume Market Share by Type (2015-2020)
14.2 Global Human Insulin Sales Revenue Market Share by Type (2015-2020)
14.3 Global Human Insulin Sales Price by Type (2015-2020)
15 Consumption Analysis by Application
15.1 Global Human Insulin Consumption Volume by Application (2015-2020)
15.2 Global Human Insulin Consumption Value by Application (2015-2020)
16 Company Profiles and Key Figures in Human Insulin Business
16.1 B. Braun
16.1.1 B. Braun Company Profile
16.1.2 B. Braun Human Insulin Product Specification
16.1.3 B. Braun Human Insulin Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.2 Sanofi
16.2.1 Sanofi Company Profile
16.2.2 Sanofi Human Insulin Product Specification
16.2.3 Sanofi Human Insulin Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.3 Biodel
16.3.1 Biodel Company Profile
16.3.2 Biodel Human Insulin Product Specification
16.3.3 Biodel Human Insulin Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.4 Becton, Dickinson
16.4.1 Becton, Dickinson Company Profile
16.4.2 Becton, Dickinson Human Insulin Product Specification
16.4.3 Becton, Dickinson Human Insulin Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.5 NOVO Nordisk
16.5.1 NOVO Nordisk Company Profile
16.5.2 NOVO Nordisk Human Insulin Product Specification
16.5.3 NOVO Nordisk Human Insulin Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.6 Biocon
16.6.1 Biocon Company Profile
16.6.2 Biocon Human Insulin Product Specification
16.6.3 Biocon Human Insulin Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.7 Ypsomed
16.7.1 Ypsomed Company Profile
16.7.2 Ypsomed Human Insulin Product Specification
16.7.3 Ypsomed Human Insulin Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.8 Julphar
16.8.1 Julphar Company Profile
16.8.2 Julphar Human Insulin Product Specification
16.8.3 Julphar Human Insulin Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.9 ELI Lilly
16.9.1 ELI Lilly Company Profile
16.9.2 ELI Lilly Human Insulin Product Specification
16.9.3 ELI Lilly Human Insulin Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.10 Wockhardt
16.10.1 Wockhardt Company Profile
16.10.2 Wockhardt Human Insulin Product Specification
16.10.3 Wockhardt Human Insulin Production Capacity, Revenue, Price and Gross Margin (2015-2020)
17 Human Insulin Manufacturing Cost Analysis
17.1 Human Insulin Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of Human Insulin
17.4 Human Insulin Industrial Chain Analysis
18 Marketing Channel, Distributors and Customers
18.1 Marketing Channel
18.2 Human Insulin Distributors List
18.3 Human Insulin Customers
19 Market Dynamics
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 Production and Supply Forecast
20.1 Global Forecasted Production of Human Insulin (2021-2026)
20.2 Global Forecasted Revenue of Human Insulin (2021-2026)
20.3 Global Forecasted Price of Human Insulin (2015-2026)
20.4 Global Forecasted Production of Human Insulin by Region (2021-2026)
20.4.1 North America Human Insulin Production, Revenue Forecast (2021-2026)
20.4.2 East Asia Human Insulin Production, Revenue Forecast (2021-2026)
20.4.3 Europe Human Insulin Production, Revenue Forecast (2021-2026)
20.4.4 South Asia Human Insulin Production, Revenue Forecast (2021-2026)
20.4.5 Southeast Asia Human Insulin Production, Revenue Forecast (2021-2026)
20.4.6 Middle East Human Insulin Production, Revenue Forecast (2021-2026)
20.4.7 Africa Human Insulin Production, Revenue Forecast (2021-2026)
20.4.8 Oceania Human Insulin Production, Revenue Forecast (2021-2026)
20.4.9 South America Human Insulin Production, Revenue Forecast (2021-2026)
20.4.10 Rest of the World Human Insulin Production, Revenue Forecast (2021-2026)
20.5 Forecast by Type and by Application (2021-2026)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2021-2026)
20.5.2 Global Forecasted Consumption of Human Insulin by Application (2021-2026)
21 Consumption and Demand Forecast
21.1 North America Forecasted Consumption of Human Insulin by Country
21.2 East Asia Market Forecasted Consumption of Human Insulin by Country
21.3 Europe Market Forecasted Consumption of Human Insulin by Countriy
21.4 South Asia Forecasted Consumption of Human Insulin by Country
21.5 Southeast Asia Forecasted Consumption of Human Insulin by Country
21.6 Middle East Forecasted Consumption of Human Insulin by Country
21.7 Africa Forecasted Consumption of Human Insulin by Country
21.8 Oceania Forecasted Consumption of Human Insulin by Country
21.9 South America Forecasted Consumption of Human Insulin by Country
21.10 Rest of the world Forecasted Consumption of Human Insulin by Country
22 Research Findings and Conclusion
23 Methodology and Data Source
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer